Analysis: Positioning to Benefit within Office Depot, ImmunoGen, Cedar Realty Trust, Carbo Ceramics, Consolidated Communications, and Catalyst Pharmaceuticals — Research Highlights Growth, Revenue, and Consolidated Results

Nov 30, 2017 13:20 pm UTC| Business

NEW YORK, Nov. 30, 2017 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Office Depot,...

Report: Exploring Fundamental Drivers Behind Time Warner, Southwest Airlines, Kohl's, MPLX LP, Horizon Global, and Farmland Partners — New Horizons, Emerging Trends, and Upcoming Developments

Nov 30, 2017 13:20 pm UTC| Business

NEW YORK, Nov. 30, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Time Warner Inc....

Interim results for the period ended 30 September 2017

Nov 30, 2017 13:17 pm UTC| Business

Highlights       ·         Golar LNG Partners LP ("Golar Partners" or "the Partnership") reports net income attributable to unit holders of $26.5 million and operating income of $53.3 million for the third quarter of...

Factors of Influence in 2018, Key Indicators and Opportunity within Yelp, Hormel Foods, Lowe's Companies, Enbridge Energy, FuelCell Energy, and Synaptics with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

Nov 30, 2017 13:10 pm UTC| Business

NEW YORK, Nov. 30, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Yelp Inc....

Report: Developing Opportunities within Procter & Gamble, ACADIA Pharmaceuticals, Cree, Umpqua, Westrock, and Globus Medical — Future Expectations, Projections Moving into 2018

Nov 30, 2017 13:10 pm UTC| Business

NEW YORK, Nov. 30, 2017 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Procter Gamble...

Targovax ASA: New member of the board of directors

Nov 30, 2017 13:04 pm UTC| Business

Oslo, Norway, 30 November 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that the extraordinary general meeting of Targovax ASA...

Interim results for the period ended 30 September 2017

Nov 30, 2017 13:05 pm UTC| Business

Highlights ·         Operating Loss and EBITDA* in the quarter reported a loss of $22.9 million and $5.5 million, respectively, compared to a 2Q 2017 loss of $24.0 million and $6.6 million, respectively. ·        ...